Definitive Contract 75N93024C00006

Award Date 3/1/24
Potential Completion Date 2/28/27
Potential Value $6.6M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
West Menlo Park, CA 94025, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
9
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $11,484,358.00 cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to SRI International, a non-profit research and development institute. The contract supports RADIOLOGICAL/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT, ADMINISTRATIVE AND TECHNICAL SUPPORT, and does not have a set-aside designation. SRI International has expertise across...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to SRI International, a non-profit research and development organization. The contract is for $575,362.67 and is a delivery order under a larger contract vehicle. The purpose is to support the development of radiation/nuclear medical countermeasures. This work aligns with NIAID's mission to conduct and support biomedical research,...
This is a cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to SRI International, a non-profit research and development institute. The contract is for $6,245,298.00 to provide radiation/nuclear medical countermeasure (MCM) product development support services, specifically animal model development and initial efficacy testing of candidate MCMs. This task order is part...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to SRI International, a non-profit research and development institute. The contract, valued at $715,633.86, is for radiation/nuclear medical countermeasure (MCM) product development support services, specifically the formulation of 3,4,3-Li(1,2-HOPO). This contract is not a set-aside and is part of a...
This is a $7,086,000 delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Sri International, a non-profit research institute, for Radiation/Nuclear Medical Countermeasure (MCM) Product Development Support Services, Animal Model Development and Initial Efficacy Testing. The contract period of performance is from September 25, 2018 to August 31, 2020, with a potential total value of...
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to the non-profit research organization SRI International. The contract, which has a ceiling value of $10,540,438.89, provides administrative and technical support services for the development of radiation/nuclear medical countermeasures (MCM). This task order is part of a larger, indefinite delivery vehicle (IDV)...
This is a $309,727.00 cost-plus-fixed-fee delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the Department of Health and Human Services (HHS) to Sri International, a nonprofit research and development institute. The contract is for the "RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON-HUMAN PRIMATE [NHP])."...
This is a $386,275 task order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to SRI International, a non-profit research and development institute. The task order is for formulation of recombinant human pleiotrophin (rhPTN) under the Radiation/Nuclear Medical Countermeasure (MCM) Product Development Support Services program. This work supports the development of medical countermeasures for...
This is a federal contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Sri International, a non-profit research institute. The contract is for radiation/nuclear medical countermeasure (MCM) product development support services, with a potential value of $15,560,740.69. The contract is a delivery order with a cost-plus-fixed-fee pricing type, and the period of performance ends on December 15,...
This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to SRI International, a non-profit research and development institute. The contract has a ceiling value of $11,180,527.00 and is a Delivery Order with a Cost Plus Fixed Fee pricing type. The contract is for animal model development and efficacy testing, with a period of performance through September 29, 2026. The contract has two subcontractors: The Medical College of...

This is a $6,607,920.00 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to SRI International, a non-profit research and development institute. The contract is for the development of a novel plasma protein biomarker panel for a radiation/nuclear triage biodosimetry device, referred to as the "RAPID RAD DX" project. This contract award is not associated with a set-aside designation. The original solicitation was a pre-solicitation notice for a Broad Agency Announcement to advance the development of candidate biodosimetry signatures/devices or medical countermeasures to assess and mitigate radiation injuries from a radiological or nuclear incident. SRI International has a history of delivering advanced research and development services to various federal agencies, including the Defense Advanced Research Projects Agency (DARPA), National Institutes of Health (NIH), and Department of Defense.

Generated 5/2/25, 10:07 AM